Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 373 entries
View as:

Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring

Phase: N/A Priority: Normal
NCT ID: NCT04460781 Org: User:
Start: 09/17/18 End: 02/28/22 Due: 02/28/23

DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants

Phase: N/A Priority: Normal
NCT ID: NCT02274285 Org: User:
Start: 10/31/14 End: 05/28/16 Due: 05/28/17

Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

Phase: N/A Priority: Normal
NCT ID: NCT00772343 Org: User:
Start: 02/28/09 End: 06/30/12 Due: 06/30/13

Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00254995 Org: User:
Start: 07/31/05 End: 05/31/13 Due: 05/31/14

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT06736041 Org: User:
Start: 12/18/24 End: 05/17/27 Due: 05/17/28

A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01089660 Org: User:
Start: 03/31/10 End: 12/31/10 Due: 12/31/11

Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants

Phase: N/A Priority: Normal
NCT ID: NCT00619502 Org: User:
Start: 12/31/07 End: 07/31/08 Due: 07/31/09

Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)

Phase: N/A Priority: Normal
NCT ID: NCT03546192 Org: User:
Start: 06/17/15 End: 07/17/15 Due: 07/17/16

Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00885105 Org: User:
Start: 10/31/05 End: 09/30/07 Due: 09/30/08

Immunogenicity and Safety of Verorab™ in Indian Population

Phase: N/A Priority: Normal
NCT ID: NCT00260351 Org: User:
Start: 12/31/04 End: 10/31/08 Due: 10/31/09

Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT01983553 Org: User:
Start: 09/10/13 End: 08/31/16 Due: 08/31/17

A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT06361875 Org: User:
Start: 04/01/24 End: 06/09/25 Due: 06/09/26

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT03205371 Org: User:
Start: 11/07/16 End: 07/19/18 Due: 07/19/19

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Phase: N/A Priority: Normal
NCT ID: NCT01427309 Org: User:
Start: 09/30/11 End: 11/30/13 Due: 11/30/14

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Phase: N/A Priority: Normal
NCT ID: NCT00802867 Org: User:
Start: 02/29/04 End: 09/30/05 Due: 09/30/06

Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01215669 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China

Phase: N/A Priority: Normal
NCT ID: NCT01933776 Org: User:
Start: 08/31/13 End: 01/31/14 Due: 01/31/15

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT03308825 Org: User:
Start: 09/11/17 End: 11/22/17 Due: 11/22/18

Recombinant Influenza Vaccine Containing Different H3 Antigens in Healthy Adults 18 to 30 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04144179 Org: User:
Start: 11/06/19 End: 02/24/20 Due: 02/24/21

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01689324 Org: User:
Start: 09/30/12 End: 05/31/13 Due: 05/31/14

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00079820 Org: User:
Start: 04/30/04 End: 10/31/06 Due: 10/31/07

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)

Phase: N/A Priority: Normal
NCT ID: NCT01138397 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03965962 Org: User:
Start: 07/01/19 End: 07/01/21 Due: 07/01/22

Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00343889 Org: User:
Start: 08/31/06 End: 04/30/08 Due: 04/30/09

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

Phase: N/A Priority: Normal
NCT ID: NCT01583049 Org: User:
Start: 03/31/12 End: 08/31/12 Due: 08/31/13